Target intelligence / Profile preview

Immunoglobulin superfamily containing leucine-rich repeat protein (ISLR)

Target
ISLR
Molecular classification
Immunoglobulin superfamily protein (IgSF), Leucine-rich repeat protein (LRR protein), Cell adhesion molecule (subclass: IgCAM in some contexts), Extracellular matrix-associated protein
01

Overview

The **Immunoglobulin superfamily containing leucine-rich repeat protein (ISLR)** is a 428-amino acid extracellular and membrane-associated protein that combines immunoglobulin-like (IgSF) domains with multiple leucine-rich repeat (LRR) motifs. The protein is highly expressed in mesenchymal stromal/stem cells, brown adipose tissue, skeletal muscle, and multiple other tissues including retina, heart, ovary, and testis. ISLR functions in cell adhesion, signaling within the extracellular matrix, and regulation of mitochondrial activity and energy homeostasis. Mechanistically, ISLR interacts with Ndufs2 to modulate IL-6 signaling, acting as a brake to prevent excess brown fat activation following muscle injury, thereby affecting whole-body energy expenditure and thermogenesis. Because of its regulatory role in muscle-adipose tissue communication and metabolic function, ISLR represents a promising novel target for metabolic disease therapeutics, although direct pharmacological targeting has not yet reached clinical application. Additionally, ISLR may serve as a marker for specific stem cell populations and is involved in developmental processes.

Other names
ISLRMeflinHsT17563mesenchymal stromal-cell and fibroblast-expressing Linx paralogueimmunoglobulin superfamily containing leucine-rich repeat
02

Mechanism of action

Modulates IL-6 signaling by interacting with NADH:Ubiquinone oxidoreductase core subunit S2 (Ndufs2)\nActs as a brake on muscle-derived IL-6, limiting brown adipose tissue activation and thermogenesis

03

Biological functions

Cell adhesionRegulation of mitochondrial functionControl of energy homeostasis and thermogenesisPlatelet degranulationRegulation of interleukin-6 (IL-6) signalingMarker of mesenchymal stromal/stem cells
04

Disease associations

Obesity/metabolic disease (potential therapeutic target in obesity)Potential involvement in tissue injury and repairMay be relevant to diseases involving energy metabolism, such as diabetes (inferred from metabolic regulation)Roles in tissue development and possibly cancer (inferred from stem cell marker status and cell adhesion functions, though direct evidence is limited)
05

Safety considerations

Potential effects on energy expenditure and thermogenesis may affect metabolic homeostasis; risks are theoretical as the therapeutic modulation is still under investigationNo established safety issues in humans as no drugs targeting ISLR are currently approved or clinically tested
06

Biomarkers

ISLR expression as a marker for mesenchymal stromal/stem cellsChanges in ISLR expression may potentially correlate with metabolic status or tissue repair; precise biomarker status needs further validation

Beyond the preview

Go deeper on Immunoglobulin superfamily containing leucine-rich repeat protein (ISLR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin superfamily containing leucine-rich repeat protein (ISLR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call